logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Hallmayer, Lars
    Company Director born in October 1974
    Individual (1 offspring)
    Officer
    icon of calendar 2022-05-16 ~ dissolved
    OF - Director → CIF 0
  • 2
    Nardi-hiebl, Stefan, Dr
    Company Director born in June 1976
    Individual (5 offsprings)
    Officer
    icon of calendar 2022-05-16 ~ dissolved
    OF - Director → CIF 0
    Dr Stefan Nardi-hiebl
    Born in June 1976
    Individual (5 offsprings)
    Person with significant control
    icon of calendar 2023-10-01 ~ dissolved
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 3
    Leiding, Petra, Dr
    Director born in February 1971
    Individual (1 offspring)
    Officer
    icon of calendar 2022-05-16 ~ dissolved
    OF - Director → CIF 0
Ceased 2
  • 1
    Mr Heinz Dieter Schnabel
    Born in November 1946
    Individual
    Person with significant control
    icon of calendar 2022-05-16 ~ 2022-12-31
    PE - Has significant influence or controlCIF 0
  • 2
    icon of address2, Lena-christ-strasse, Gruenwald, Germany
    Corporate
    Person with significant control
    2023-05-23 ~ 2023-10-01
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

ANESTPHARMA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
80,926 GBP2024-10-31
100,534 GBP2023-12-31
Current Assets
80,926 GBP2024-10-31
100,534 GBP2023-12-31
Net Current Assets/Liabilities
80,926 GBP2024-10-31
86,417 GBP2023-12-31
Total Assets Less Current Liabilities
80,926 GBP2024-10-31
86,417 GBP2023-12-31
Net Assets/Liabilities
80,926 GBP2024-10-31
86,417 GBP2023-12-31
Equity
Called up share capital
150,000 GBP2024-10-31
150,000 GBP2023-12-31
Retained earnings (accumulated losses)
-69,074 GBP2024-10-31
-63,583 GBP2023-12-31
Amount of value-added tax that is recoverable
Current
808 GBP2024-10-31
534 GBP2023-12-31
Called-up share capital (not paid)
Current
80,118 GBP2024-10-31
100,000 GBP2023-12-31
Trade Creditors/Trade Payables
Current
1 GBP2023-12-31
Other Creditors
Current
7,839 GBP2023-12-31
Amounts owed to directors
Current
6,277 GBP2023-12-31

  • ANESTPHARMA LIMITED
    Info
    Registered number 14110216
    icon of address1 Park Row, Leeds LS1 5AB
    Private Limited Company incorporated on 2022-05-16 and dissolved on 2025-01-21 (2 years 8 months). The company status is Dissolved.
    The last date of confirmation statement was made at 2024-05-29
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 26 August 2025 and licensed under the Open Government Licence v3.0.